Literature DB >> 23462714

Improvement of σ1 receptor affinity by late-stage C-H-bond arylation of spirocyclic lactones.

Christina Meyer1, Benedikt Neue, Dirk Schepmann, Shuichi Yanagisawa, Junichiro Yamaguchi, Ernst-Ulrich Würthwein, Kenichiro Itami, Bernhard Wünsch.   

Abstract

The direct C-H-bond arylation of the complex spirocyclic lactones 13, 14, and 18 allows the introduction of diverse aryl moieties in the last step of the synthesis. A selective α-arylation of the thiophene moiety was performed with the catalytic system PdCl2/2,2'-bipyridyl/Ag2CO3, whereas the β-position of the thiophene ring was addressed by using the alternative catalytic system PdCl2/P[OCH(CF3)2]3/Ag2CO3. Due to electronic and steric reasons the arylation of the five-membered lactone 18 occurred in both α-positions providing 4'-mono-, 6'-mono- and 4',6'-diarylated thiophenes 22-26a-c. Compounds with an additional aryl moiety at the 'upper left (top)' position (1'-position of 13, 3'-position of 14, 4'-position of 18) showed increased σ1 affinity compared to the non-arylated parent compounds. A phenyl moiety at the 'left' position (2'-position in 20a) also increased the σ1 affinity but to a lower extent. A considerable reduction of σ1 affinity was observed after introducing an aryl moiety in 6'-position of 18, which might result from shielding the tertiary amine, which is crucial for interaction with the σ1 receptor. The discussion of the experimental results is supported by high-level quantum chemical DFT-calculations of the NBO-charges of 13 and 18 and the relative energies of the related arylated products.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23462714     DOI: 10.1016/j.bmc.2013.01.038

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  11 in total

1.  Propellanes as Rigid Scaffolds for the Stereodefined Attachment of σ-Pharmacophoric Structural Elements to Achieve σ Affinity.

Authors:  Héctor Torres-Gómez; Constantin Daniliuc; Dirk Schepmann; Erik Laurini; Sabrina Pricl; Bernhard Wünsch
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

2.  Do GluN2B subunit containing NMDA receptors tolerate a fluorine atom in the phenylalkyl side chain?

Authors:  Yoshihiro Shuto; Simone Thum; Louisa Temme; Dirk Schepmann; Masato Kitamura; Bernhard Wünsch
Journal:  Medchemcomm       Date:  2017-03-17       Impact factor: 3.597

3.  Synthesis and receptor binding of thiophene bioisosteres of potent GluN2B ligands with a benzo[7]annulene-scaffold.

Authors:  Sören Baumeister; Dirk Schepmann; Bernhard Wünsch
Journal:  Medchemcomm       Date:  2019-01-10       Impact factor: 3.597

4.  Asymmetric Synthesis of Spirocyclic 2-Benzopyrans for Positron Emission Tomography of σ1 Receptors in the Brain.

Authors:  Katharina Holl; Dirk Schepmann; Steffen Fischer; Friedrich-Alexander Ludwig; Achim Hiller; Cornelius K Donat; Winnie Deuther-Conrad; Peter Brust; Bernhard Wünsch
Journal:  Pharmaceuticals (Basel)       Date:  2014-01-22

5.  Enantiomerically Pure Quinoline-Based κ-Opioid Receptor Agonists: Chemoenzymatic Synthesis and Pharmacological Evaluation.

Authors:  Benedikt Martin; Dirk Schepmann; Freddy A Bernal; Thomas J Schmidt; Tao Che; Karin Loser; Bernhard Wünsch
Journal:  ChemMedChem       Date:  2020-07-02       Impact factor: 3.466

6.  Synthesis and Pharmacological Evaluation of Fluorinated Quinoxaline-Based κ-Opioid Receptor (KOR) Agonists Designed for PET Studies.

Authors:  Giovanni Tangherlini; Frederik Börgel; Dirk Schepmann; Samuel Slocum; Tao Che; Stefan Wagner; Katrin Schwegmann; Sven Hermann; Nadine Mykicki; Karin Loser; Bernhard Wünsch
Journal:  ChemMedChem       Date:  2020-09-01       Impact factor: 3.466

7.  Synthesis of Aminoethyl-Substituted Piperidine Derivatives as σ1 Receptor Ligands with Antiproliferative Properties.

Authors:  Catharina Holtschulte; Frederik Börgel; Stefanie Westphälinger; Dirk Schepmann; Gianluca Civenni; Erik Laurini; Domenico Marson; Carlo V Catapano; Sabrina Pricl; Bernhard Wünsch
Journal:  ChemMedChem       Date:  2022-02-09       Impact factor: 3.540

8.  Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective.

Authors:  Antonino N Fallica; Valeria Pittalà; Maria N Modica; Loredana Salerno; Giuseppe Romeo; Agostino Marrazzo; Mohamed A Helal; Sebastiano Intagliata
Journal:  J Med Chem       Date:  2021-06-02       Impact factor: 7.446

9.  Synthesis and σ receptor affinity of spiro[[2]benzopyran-1,1'-cyclohexanes] with an exocyclic amino moiety in the 3'-position.

Authors:  Elisabeth Kronenberg; Frauke Weber; Dirk Schepmann; Bernhard Wünsch
Journal:  RSC Med Chem       Date:  2020-12-09

10.  [2.2]Paracyclophane-Based TCN-201 Analogs as GluN2A-Selective NMDA Receptor Antagonists.

Authors:  Remya Rajan; Dirk Schepmann; Ruben Steigerwald; Julian A Schreiber; Ehab El-Awaad; Joachim Jose; Guiscard Seebohm; Bernhard Wünsch
Journal:  ChemMedChem       Date:  2021-08-03       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.